Why Us?
At Par Health, we believe great healthcare is built on getting the essentials right. We’re looking for passionate, talented individuals who share our commitment to improving lives. With a global workforce, we lead with pride and purpose—prioritizing quality and safety while fostering a culture of continuous improvement, accountability, and teamwork. Elevating the Essentials isn’t just our tagline, it’s the higher standard we live by every day.
The Global Safety Leader (GSL) is responsible, with limited supervision, for all medical aspects of safety assessment and the safety risk management strategy of products in every stage of product life cycle worldwide for Par Health.
A. Comprehensive review of all available safety data including current and historical medical and scientific literature, the global safety database and relevant clinical trial data.
B. Assessment of the causal association between a product-event pair, using current threshold criteria. Safety results are periodically presented and defended before a management review panel (Safety Review Board).
C. Following approval of signals, the GSL along with Regulatory Affairs will coordinate a Label Working Group to update the United States Prescribing Information (USPI) and/or plan public communication for new safety findings. If applicable, along with Regulatory Affairs will coordinate the Company Core Safety Information (CCSI) working groups. CCSI WG may update existing CCSI with new safety findings or create a new CCSI. The GSL will develop project plans and timelines to support the Label WG and CCSI WG activities, assist in drafting USPI and CCSI revisions and provide supporting documentation.
Health care professional with post graduate medical qualification (MD/DO or equivalent)
Preferred Skills/Qualifications:
· Sr. Dir, Pharmacovigilance & Risk Management (PVRM)
· Interact with a variety of Corporate Divisions. These include, but are not limited to, Legal, Regulatory Affairs, Medical Information, Pharmacovigilance, R&D, Marketing, Quality Assurance, Sales, and Customer Service. The degree and scope will vary according to the needs of the departments involved
· Remote eligible
· Occasional travel may be required for such things as training seminars, manufacturing site visits, and professional/trade conventions.
The above statements are intended to describe the general nature and level of work being performed by employees assigned to this classification. They are not intended to be construed as an exhaustive list of all responsibilities, duties and skills required of employees assigned to this position.
We comply with all applicable federal, state, and local laws prohibiting discrimination and harassment, and provides equal employment opportunities (EEO) to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, gender identity, national origin, age, disability, veteran status, or genetic information, or any other classification protected by federal, state or local law. This policy applies to all terms and conditions of employment, including recruiting, hiring, placement, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training.

Endo combined with Mallinckrodt Pharmaceuticals in 2025 to better serve customers and improve outcomes for the patients we support.
From this union, we established two focused, standalone companies:
– Keenova Therapeutics, a branded therapeutics business
– Par Health, a generics and sterile injectables business
To learn more, follow Keenova and Par Health on LinkedIn and visit keenova.com and parhealth.com.